Physician

Matthew Charles Werthammer, MD

According to 2025 Medicare claims, Matthew Werthammer, MD (NPI: 1912133570) practices neurosurgery in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Cabell, WV. This provider's primary affiliated billing organization is ST. MARY'S MEDICAL MANAGEMENT, LLC (NPI: 1922155217; TIN: 208017790) and primary practice location at 25702-1241. Werthammer is affiliated with the ACO West Virginia (ACO ID: A3563) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Werthammer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 313 traditional Medicare patients, billed 594 HCPCS/CPT codes, and received $166,488 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 216 prescription claims across 85 beneficiaries totaling $1,955 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). 2023 DME data shows 11 claims. Open Payments data shows 1 records totaling $22. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $243,533 to $166,488. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $8,066 to $1,955. For DME billing, reported payments moved sharply higher in recent years, from $905 to $1,148.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$122K$244K2015 Medicare payment: $243,533 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $232,780 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $231,166 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $159,222 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $210,609 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $191,640 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $200,677 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $168,121 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $149,058 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $166,488 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155001,009$243,533
2016509964$232,780
2017477870$231,166
2018344593$159,222
2019494777$210,609
2020387716$191,640
2021358750$200,677
2022352639$168,121
2023275556$149,058
2024313594$166,488

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.0K$8.1K2015 Drug cost: $8,066 (USD; Tot_Drug_Cst)2016 Drug cost: $7,938 (USD; Tot_Drug_Cst)2017 Drug cost: $5,407 (USD; Tot_Drug_Cst)2018 Drug cost: $3,120 (USD; Tot_Drug_Cst)2019 Drug cost: $2,515 (USD; Tot_Drug_Cst)2020 Drug cost: $2,165 (USD; Tot_Drug_Cst)2021 Drug cost: $2,179 (USD; Tot_Drug_Cst)2022 Drug cost: $2,378 (USD; Tot_Drug_Cst)2023 Drug cost: $2,749 (USD; Tot_Drug_Cst)2024 Drug cost: $1,955 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015105336$8,066
2016110315$7,938
2017102285$5,407
201886235$3,120
201994244$2,515
202090214$2,165
2021121282$2,179
2022108244$2,378
202389231$2,749
202485216$1,955

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$11K$23K2015 Medicare payment: $21,814 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $15,683 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $18,498 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $10,382 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $22,880 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $14,082 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $22,001 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $13,625 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $188 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20152525$21,814
20161919$15,683
20172121$18,498
20181212$10,382
20192525$22,880
20201526$14,082
20212349$22,001
20221348$13,625
2023N/R11$188
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more5656$142
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes9194$138
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more3135$115
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more126126$103
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes3447$63

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34596$857
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen52399$444
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst1686$117
MethylprednisoloneMethylprednisolone1378$108
Cyclobenzaprine HclCyclobenzaprine Hcl43466$92

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$22Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Charles Werthammer, MD?

Tedicare shows public-source Medicare data for Matthew Charles Werthammer, MD (NPI 1912133570), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Charles Werthammer, MD have ACO affiliation data?

Matthew Charles Werthammer, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Matthew Charles Werthammer, MD?

Matthew Charles Werthammer, MD is linked to ST. MARY'S MEDICAL MANAGEMENT, LLC (billing NPI 1922155217) in the available physician profile data.

Does Matthew Charles Werthammer, MD have Open Payments data?

Matthew Charles Werthammer, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.